1 June 2005 in Nature Reviews Immunology
30 April 2001 in Oncogene
CLCristina López-Rodríguez
15 February 2004 in Nature Immunology
1 September 2000 in The EMBO Journal
Cooperation between nuclear factor of activated T cells (NFAT) and AP‐1 (Fos–Jun) proteins on composite NFAT–AP‐1 DNA elements constitutes a powerful mechanism for signal integration of the calcium and protein kinase C/Ras pathways in the regulation of gene expression. Here we report that NFAT can induce expression of certain genes in T cells without the need for cooperative recruitment of Fos and Jun. Using NFAT1 mutant proteins that are unable to interact with Fos–Jun dimers but are unaffected in DNA binding or transcriptional activity, we show that expression of interleukin (IL)‐2, granulocyte–macrophage colony‐stimulating factor (GM‐CSF), IL‐3, IL‐4, MIP1α and Fas ligand mRNAs is absolutely dependent on cooperation between NFAT and Fos–Jun; in contrast, NFAT induces tumor necrosis factor α (TNFα) mRNA and IL‐13 promoter activity without any necessity to recruit Fos and Jun. Furthermore, we show that NFAT–Fos–Jun cooperation is also essential to elicit the NFAT‐dependent program of activation‐induced cell death. Our results support the hypothesis that even in a single cell type, NFAT activation can evoke two distinct biological programs of gene expression, dependent or independent of NFAT–AP‐1 cooperation.
12 October 2011 in The Journal of Pathology
Autophagy is a process traditionally known to contribute to cellular cleaning through the removal of intracellular components in lysosomes. In recent years, intensive scrutiny at the molecular level to which autophagy has been subjected has also contributed to expanding our understanding of the physiological role of this pathway. Added to the well‐characterized role in quality control, autophagy has proved to be important in the maintenance of cellular homeostasis and of the energetic balance, in cellular and tissue remodelling, and cellular defence against extracellular insults and pathogens. It is not a surprise that, in light of this growing number of physiological functions, connections between autophagic malfunction and human pathologies have also been strengthened. In this review, we focus on several pathological conditions associated with primary or secondary defects in autophagy and comment on a recurring theme for many of them, ie the fact that autophagy can often exert both beneficial and aggravating effects on the progression of disease. Elucidating the factors that determine the switch between these dual functions of autophagy in disease has become a priority when considering the potential therapeutic implications of the pharmacological modulation of autophagy in many of these pathological conditions. Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.